Camp4 Therapeutics (CAMP) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Camp4 Therapeutics Corporation  (NASDAQ: CAMP)


Camp4 Therapeutics's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Camp4 Therapeutics's ROA in the second quarter of 2026?
Camp4 Therapeutics Corporation recorded a cumulative net loss of $-107 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -106.42%.

However, within the Healthcare sector 751 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4235, from total ROA ranking in the first quarter of 2026 at 4952.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 82.21 % 68 % 57.41 % 304.4 % -81.28 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -107 -86 -80 -53 -52
Return On Assets (TTM) -106.42 % -95.64 % -101.06 % -77.59 % -98.52 %
CAMP's Total Ranking # 4235 # 4952 # 4256 # 4442 # 52
Total Assets (TTM) in million 93 105 118 86 51
Seq. Total Assets Change -11.41 % -10.48 % 36.36 % 68.49 % -18.32 %
Seq. Net Income Change - - - - -

CAMP's 5 Years Annual ROA >> Back to CAMP Management Effectiveness >> Compare CAMP ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 350
Sector # 752
Overall # 4245

Return On Assets Statistics
High Average Low
146.34 %
-0.83 %
-106.42 %
(Dec 31 2024)   (Jun 30 2026)



  News about Camp4 Therapeutics Corporation Return on Assets ROA

CAMP4 and CalAmp: Leading the Charge in Biotechnology and Consumer Electronics with Strategic Advancements,

The Future of Biotech and Tech: CAMP4 Therapeutics and CalAmp Navigate Transition and Innovation Amid Industry ChallengesIn an era defined by rapid technological advancement and groundbreaking medical innovation, the biotechnology and consumer electronics sectors are under immense pressure to evolve and remain competitive. Two companies at the forefront of these changes, CAMP4 Therapeutics (CAMP4) and CalAmp, are strategically addressing their respective challenges while positioning themselves for future growth. Recent corporate updates from CAMP4 and a financial restructuring by CalAmp underscore their commitment to innovation and long-term success.CAMP4 Therapeutics: Pioneering gene regulation for the futureCAMP4 Therapeutics, a clinical-stage biotech firm based in Cambridge, Massachusetts, has announced significant corporate updates that highlight its ambition to lead in the realm of gene regulation. The company is known for its development of regRNA-targeting antisense oligonucleotide therapies designed to upregulate gene expression. By restoring healthy protein levels, these therapies have the potential to address a myriad of genetic conditions that have long resisted effective treatment.



Financial Statements
Camp4 Therapeutics's Assets $ 93 million CAMP's Balance sheet
Camp4 Therapeutics's Income $ -34 million Quarterly CAMP's Income Statement
CAMP's Income by Division See CAMP's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Feb 28 2023)
FY 2023		 (Feb 28 2022)
FY 2022		 (Feb 28 2021)
FY 2021
Y / Y Total Assets Change 60.85 % -80.23 % -2.88 % -9.28 % -12.11 %
Total Assets in million 118 73 370 381 420
Y / Y Net Income Change - - - - -
Net Income in million -80 -52 -32 -28 -56
Annual Return On Assets -68.25 % -70.71 % -8.77 % -7.34 % -13.39 %

CAMP's 5 Years Annual ROA >> Back to CAMP Management Effectiveness >> Compare CAMP ROA to its Competitors



More Return On Assets Ratios
CAMP's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CAMP's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CAMP's Competitors
Subscribers only: Roa for Camp4 Therapeutics's Suppliers
Subscribers only: Return On Assets for CAMP's Customers

You may also want to know
CAMP's Roi CAMP's Inventory Turnover Ratio CAMP's Growth Rates CAMP's Dividend Comparisons
CAMP's Profitability Ratios CAMP's Asset Turnover Ratio CAMP's Dividend Growth
CAMP's Roe CAMP's Valuation Ratios CAMP's Financial Strength Ratios CAMP's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-26T07:43:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.